These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 30170276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design, synthesis and evaluation of d-amino acid-containing peptidomimetics targeting the polo-box domain of polo-like kinase 1.
    Li Z, Zhang Z, Chen Y, Tang S, Lin T, Huang J, Li B, Jiang C.
    Bioorg Chem; 2019 Apr; 85():534-540. PubMed ID: 30807896
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel peptidomimetics targeting the polo-box domain of polo-like kinase 1.
    Li Z, Zhang Z, Sun H, Xu L, Jiang C.
    Bioorg Chem; 2019 Oct; 91():103148. PubMed ID: 31376784
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors.
    Yun T, Qin T, Liu Y, Lai L.
    Eur J Med Chem; 2016 Nov 29; 124():229-236. PubMed ID: 27592392
    [Abstract] [Full Text] [Related]

  • 6. Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain.
    Chen Y, Zhang J, Li D, Jiang J, Wang Y, Si S.
    Oncotarget; 2017 Jan 03; 8(1):1234-1246. PubMed ID: 27902479
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors.
    Lin TY, Min HP, Jiang C, Niu MM, Yan F, Xu LL, Di B.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3429-3437. PubMed ID: 29807699
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1.
    Ryu S, Park JE, Ham YJ, Lim DC, Kwiatkowski NP, Kim DH, Bhunia D, Kim ND, Yaffe MB, Son W, Kim N, Choi TI, Swain P, Kim CH, Lee JY, Gray NS, Lee KS, Sim T.
    J Med Chem; 2022 Feb 10; 65(3):1915-1932. PubMed ID: 35029981
    [Abstract] [Full Text] [Related]

  • 10. Development of Bifunctional Inhibitors of Polo-Like Kinase 1 with Low-Nanomolar Activities Against the Polo-Box Domain.
    Scharow A, Knappe D, Reindl W, Hoffmann R, Berg T.
    Chembiochem; 2016 Apr 15; 17(8):759-67. PubMed ID: 26634982
    [Abstract] [Full Text] [Related]

  • 11. Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain.
    Yan F, Liu G, Chen T, Fu X, Niu MM.
    Molecules; 2019 Dec 27; 25(1):. PubMed ID: 31892137
    [Abstract] [Full Text] [Related]

  • 12. Dynamic and multi-pharmacophore modeling for designing polo-box domain inhibitors.
    Sakkiah S, Senese S, Yang Q, Lee KW, Torres JZ.
    PLoS One; 2014 Dec 27; 9(7):e101405. PubMed ID: 25036740
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1.
    Srinivasrao G, Park JE, Kim S, Ahn M, Cheong C, Nam KY, Gunasekaran P, Hwang E, Kim NH, Shin SY, Lee KS, Ryu E, Bang JK.
    PLoS One; 2014 Dec 27; 9(9):e107432. PubMed ID: 25211362
    [Abstract] [Full Text] [Related]

  • 14. Identification of a high affinity selective inhibitor of Polo-like kinase 1 for cancer chemotherapy by computational approach.
    Kumar M, Pydi SP, Sharma S, Singh TP, Kaur P.
    J Mol Graph Model; 2014 Jun 27; 51():104-12. PubMed ID: 24879322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
    Shan HM, Shi Y, Quan J.
    ChemMedChem; 2015 Jan 27; 10(1):158-63. PubMed ID: 25196850
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
    Kim TG, Lee JH, Lee MY, Kim KU, Lee JH, Park CH, Lee BH, Oh KS.
    Biol Pharm Bull; 2017 Jan 27; 40(9):1454-1462. PubMed ID: 28867728
    [Abstract] [Full Text] [Related]

  • 20. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
    Reindl W, Strebhardt K, Berg T.
    Anal Biochem; 2008 Dec 15; 383(2):205-9. PubMed ID: 18793607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.